Tech Company M&A Transactions
Morphotek Acquisition
Morphotek, operating out of Exton, was acquired by Eisai of North America. Financial terms set the valuation at $325 million.
Transaction Overview
Company Name
Acquired By
Announced On
3/22/2007
Transaction Type
M&A
Amount
$325,000,000
M&A Terms
ECA has signed a definitive agreement to acquire Morphotek for US$325 million after excess net cash.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
210 Welsh Pool Road
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Website
Email Address
Not Recorded
Overview
Morphotek is a biopharmaceutical company developing therapeutic monoclonal antibodies through the use of a proprietary human antibody technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Nicolaides
Browse more venture capital transactions:
Prev: 3/22/2007: ChemoCentryx venture capital transaction
Next: 3/22/2007: Skylight Healthcare Systems venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs